Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00006057 · ClinicalTrials.gov registry record
Diagnostic and Screening Study of Genetic Disorders
A clinical trial, sponsored by National Center for Research Resources (NCRR).
- Completed
- Registry status
- 50
- Enrollment target
NCT00006057: Completed study, sponsored by National Center for Research Resources (NCRR).
NCT00006057 is a clinical trial that has completed, run by National Center for Research Resources (NCRR). The registered enrollment target is 50 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00006057 has completed, sponsored by National Center for Research Resources (NCRR).
- COMPLETED
- Registry status
- 50 participants
- Enrollment target
Study Summary
OBJECTIVES: I. Determine the phenotypic heterogeneity of patients with genetic disorders including their clinical spectrum and natural history. II. Develop and evaluate novel methods for the treatment of genetic disorders including metabolic manipulation, enzyme manipulation, enzyme replacement, enzyme transplantation, and gene transfer techniques in these patients. III. Develop and evaluate methods for the prenatal diagnosis of genetic disorders using improved cytogenetic, biochemical, and nucleic acid techniques and amniotic fluid cells or chorionic villi in these patients.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 1999-12 |
What the finished NCT00006057 record still lists
NCT00006057 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 50 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT00006057 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00006057 about?
NCT00006057 is a clinical study titled "Diagnostic and Screening Study of Genetic Disorders". OBJECTIVES: I. Determine the phenotypic heterogeneity of patients with genetic disorders including their clinical spectrum and natural history. II. Develop and evaluate novel methods for the treatment of genetic disorders including metabolic manipulation, enzyme manipulation, enzyme replacement, en...
What is the current status of trial NCT00006057?
This trial is currently completed. The enrollment target is 50 participants. The study started on 1999-12.
Who is sponsoring clinical trial NCT00006057?
This trial is sponsored by National Center for Research Resources (NCRR), which has 94 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia